Detalles de la búsqueda
1.
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
Cardiovasc Diabetol
; 22(1): 126, 2023 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244998
2.
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Cardiovasc Diabetol
; 22(1): 233, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653496
3.
Subcutaneous Semaglutide Use for Weight Management: Practice and Attitudes of Physicians in Israel.
Isr Med Assoc J
; 25(10): 664-668, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846993
4.
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
Cardiovasc Diabetol
; 21(1): 104, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35689214
5.
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
Diabetes Obes Metab
; 24(7): 1277-1287, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322567
6.
Temporal patterns selection for All-Cause Mortality prediction in T2D with ANNs.
J Biomed Inform
; 134: 104198, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100163
7.
Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence.
Cardiovasc Diabetol
; 20(1): 169, 2021 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407822
8.
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Cardiovasc Diabetol
; 20(1): 159, 2021 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332558
9.
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.
Diabetes Obes Metab
; 23(6): 1431-1435, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606906
10.
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs.
Cardiovasc Diabetol
; 18(1): 115, 2019 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31472683
11.
Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data.
Diabetes Obes Metab
; 25(10): 3054-3058, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385956
12.
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG).
Cardiovasc Diabetol
; 16(1): 137, 2017 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061170
13.
Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy.
J Perinat Med
; 42(3): 371-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24334424
14.
Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells.
Med Oncol
; 41(6): 138, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38705935
15.
Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease.
Clin J Am Soc Nephrol
; 18(9): 1153-1162, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382938
16.
SipNose-topiramate: a potential novel approach to binge eating management.
J Eat Disord
; 11(1): 102, 2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365668
17.
Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data.
PLoS One
; 18(5): e0285606, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37216375
18.
Prevalence, outcomes and costs of a contemporary, multinational population with heart failure.
Heart
; 109(7): 548-556, 2023 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36781285
19.
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Diabetes Metab
; 49(2): 101418, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36608816
20.
The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Breast Cancer Res Treat
; 132(2): 449-61, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21638053